Guangqing Xiao

1.8k citations

28 papers · 1.2k indexed · h-index 20

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 6
Oncology top 5%
- Drug Transport and Resistance Mechanisms 14
Pediatrics, Perinatology and Child Health top 5%
- Pharmacological Effects and Toxicity Studies 10
Physiology top 5%
Biochemistry top 10%
- Amino Acid Enzymes and Metabolism 4
Epidemiology
- Liver Disease Diagnosis and Treatment 4
Cell Biology
- Endoplasmic Reticulum Stress and Disease 3
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 3
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 2

Co-authors: Liang‐Shang Gan Kathleen M. Giacomini Xiaoyan Chu Jashvant D. Unadkat Laurent Salphati Richard E. Fine Robin J. Johnson Cornelis E. C. A. Hop
Cited by: Pharmacology Oncology Pediatrics, Perinatology and Child Health
Journals: Molecular Pharmacology (2 papers)Pharmaceutical Research (3 papers)Clinical Pharmacology & Therapeutics (3 papers)
Partner nations: United States China Japan

In The Last Decade

Guangqing Xiao

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Guangqing Xiao

Since Specialization

Citations

This map shows the geographic impact of Guangqing Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangqing Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangqing Xiao more than expected).

Fields of papers citing papers by Guangqing Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangqing Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangqing Xiao. The network helps show where Guangqing Xiao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guangqing Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guangqing Xiao Line = papers co-authored together Guangqing Xiao links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Resveratrol Attenuates Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via TLR-4 Mediated Inflammation in C57BL/6 Mice Physiological Research ·Zhuoying Chen,Guangqing Xiao,J Ao	2024	13
2	A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects Clinical Pharmacokinetics ·Hironobu Tsukada,Yu‐Luan Chen,Guangqing Xiao,Lisa Lennek,Snežana Milanović,MaryAlice Worden,Daniel Polhamus,Yu‐Yuan Chiu,Seth C. Hopkins,Gerald R. Galluppi	2023	4
3	In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia Pharmaceutical Research ·Guangqing Xiao,Yu‐Luan Chen,Nina Dedic,Linghong Xie,Kenneth S. Koblan,Gerald R. Galluppi	2022	11
4	Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach Drug Metabolism and Disposition ·Vineet Kumar,Mengyue Yin,Kazuya Ishida,Laurent Salphati,Cornelis E. C. A. Hop,Christopher Rowbottom,Guangqing Xiao,Yurong Lai,Anita Mathias,Xiaoyan Chu,W. Griffith Humphreys,Mingxiang Liao,Zsuzsanna Nerada,Nóra Szilvásy,Scott Heyward,Jashvant D. Unadkat	2020	27
5	Positron Emission Tomography Imaging of [¹¹C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A Clinical Pharmacology & Therapeutics ·Sarah Billington,Steven C. Shoner,Scott D. Lee,Kindra Clark‐Snustad,Matthew R. Pennington,David H. Lewis,Mark Muzi,Shirley Rene,Jean Lee,Tot Bui Nguyen,Vineet Kumar,Kazuya Ishida,Laigao Chen,Xiaoyan Chu,Yurong Lai,Laurent Salphati,Cornelis E. C. A. Hop,Guangqing Xiao,Mingxiang Liao,Jashvant D. Unadkat	2019	50
6	Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics Clinical Pharmacology & Therapeutics ·Sarah Billington,Laurent Salphati,Cornelis E. C. A. Hop,Xiaoyan Chu,Raymond Evers,Doug Burdette,Christopher Rowbottom,Yurong Lai,Guangqing Xiao,W. Griffith Humphreys,Tot Bui Nguyen,Bhagwat Prasad,Jashvant D. Unadkat	2019	60
7	A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation Drug Metabolism and Disposition ·Vineet Kumar,Laurent Salphati,Cornelis E. C. A. Hop,Guangqing Xiao,Yurong Lai,Anita Mathias,Xiaoyan Chu,W. Griffith Humphreys,Mingxiang Liao,Scott Heyward,Jashvant D. Unadkat	2019	38
8	Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators Bioorganic & Medicinal Chemistry Letters ·Bin Ma,Brian S. Lucas,Andrew G. Capacci,Edward Yin-Shiang Lin,J. Howard Jones,Michael A. Dechantsreiter,Istvan Enyedy,D.J. Marcotte,Guangqing Xiao,Bing Li,K. Richter	2019	30
9	Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K Pharmaceutical Research ·Guangqing Xiao,Christopher Rowbottom,Carri Boiselle,Liang‐Shang Gan	2018	9
10	A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans Journal of Pharmacokinetics and Pharmacodynamics ·Konstantinos Biliouris,Ivan Nestorov,Himanshu Naik,David Dai,Guangqing Xiao,Qin Wang,Alex Pellerin,Dania Rabah,Lawrence J. Lesko,Mirjam N. Trame	2018	12
11	Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study Drug Metabolism and Disposition ·Bhagwat Prasad,Deepak Bhatt,Katherine Johnson,Revathi Chapa,Xiaoyan Chu,Laurent Salphati,Guangqing Xiao,Caroline Lee,Cornelis E. C. A. Hop,Anita Mathias,Yurong Lai,Mingxiang Liao,W. Griffith Humphreys,Sean Kumer,Jashvant D. Unadkat	2018	72
12	Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics Drug Metabolism and Disposition ·Piyush Bajaj,Swapan K. Chowdhury,Robert W. Yucha,Edward J. Kelly,Guangqing Xiao	2018	67
13	Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics Clinical Pharmacology & Therapeutics ·Bhagwat Prasad,Andrea Gaedigk,Marc Vrana,Roger Gaedigk,JS Leeder,Laurent Salphati,Xiaoyan Chu,Guangqing Xiao,CECA Hop,Raymond Evers,Liang‐Shang Gan,Jashvant D. Unadkat	2016	113
14	Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper Drug Metabolism and Disposition ·Eugenia Kraynov,Ajith V. Kamath,Markus Walles,Edit Tarcsa,Antoine Deslandes,Ramaswamy A. Iyer,Amita Datta‐Mannan,P. Sriraman,Michaela Bairlein,Johnny Yang,Michael E. Barfield,Guangqing Xiao,Enrique Escandón,W. Wang,Dan A. Rock,Nagendra Chemuturi,David J. Moore	2015	70
15	Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells American Journal of Physiology-Renal Physiology ·Lara M. Mangravite,Guangqing Xiao,Kathleen M. Giacomini	2003	65
16	Interactions of n-Tetraalkylammonium Compounds and Biguanides with a Human Renal Organic Cation Transporter (hOCT2) Pharmaceutical Research ·Mark J. Dresser,Guangqing Xiao,Maya K. Leabman,Andrew T. Gray,Kathleen M. Giacomini	2002	68
17	A Novel Proton-Dependent Nucleoside Transporter, CeCNT3, fromCaenorhabditis elegans Molecular Pharmacology ·Guangqing Xiao,Juan Wang,Tonje Tangen,Kathleen M. Giacomini	2001	27
18	Calreticulin functions as a molecular chaperone for the β-amyloid precursor protein 1 1Abbreviations used: Aβ, β-amyloid peptide; AD, Alzheimer’s disease; APP, β-amyloid precursor protein; CHAPS, 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propanesulfonate; Crt, calreticulin; DMEM, Dulbecco’s Modified Eagle Medium; DMJ, deoxymannojirimycin; DTSSP, 3,3′-Dithio bis (sulfosuccinimidylpropionate); ECL, Enhanced Chemiluminescence; ER, endoplasmic reticulum; FBS, fetal bovine serum; HRP, horseradish peroxidase; kDa, kiloDaltons; MES, 2-(N-Morpholino) ethane sulfonic acid; NRS, normal rabbit serum; PBS, PBS; PMSF, phenymethylsulfonyl fluoride; PVDF, polyvinylidene fluoride. Neurobiology of Aging ·Robin J. Johnson,Guangqing Xiao,Janani Shanmugaratnam,Richard E. Fine	2001	37
19	KDEL proteins are found on the surface of NG108-15 cells Molecular Brain Research ·Guangqing Xiao,Tzu-Feng Chung,Hae Yung Pyun,Richard E. Fine,Robin J. Johnson	1999	89
20	Calreticulin is transported to the surface of NG108-15 cells where it forms surface patches and is partially degraded in an acidic compartment Journal of Neuroscience Research ·Guangqing Xiao,Tzu-Feng Chung,Richard E. Fine,Robin J. Johnson	1999	30

About Guangqing Xiao

Guangqing Xiao is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Biochemistry, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (10 papers), Pharmacogenetics and Drug Metabolism (6 papers), Amino Acid Enzymes and Metabolism (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Pharmacology (262 citations), Oncology (555 citations) and Pediatrics, Perinatology and Child Health (308 citations). Guangqing Xiao has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Liang‐Shang Gan, Kathleen M. Giacomini, Xiaoyan Chu, Jashvant D. Unadkat, Laurent Salphati, Richard E. Fine, Robin J. Johnson, Cornelis E. C. A. Hop, Yurong Lai and Raymond Evers. Their work appears in journals such as Molecular Pharmacology, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact